|
DAY 3 - October 12, 2010 (Non CME-Accredited)
FREE TO ATTEND
The purpose of this conference is to highlight the importance of early diagnosis and aggressive treatment for persons living with one of the hundred forms of arthritis. Today, with the advent of biologic medication, arthritis patients should not become disabled, but become contributing members of society and fulfill their choice to work, support families and most importantly have a feeling of self-worth as they learn to live with this chronic disease. With medications costing up to AED 80,000, get behind us to find an answer to help those living with arthritis.
|
|
|
Focus for Insurance companies and Health care Policymakers to reduce the burden of Arthritis
Chairpersons:
Dr. Haider Al Attia, Rheumatologist at Al Noor Hospital, Abu Dhabi
Dr. Waleed AlShehhi, Consultant Rheumatologist at Al Biraa Arthritis & Bone Centre, Dubai |
|
9.00am |
Introduction: Emirates Arthritis Foundation, The Purpose
Katrina Thornely, Patient Support Director of Emirates Arthritis Foundation |
|
9.10am |
What Is Arthritis And The Advent Of Biologic Treatment
Dr. Haider Al Attia, Rheumatologist, Al Noor Hospital, <밤త>Abu Dhabi |
|
9.30am |
Access to Arthritic Healthcare in the UAE
Dr. Waleed AlShehhi, Consultant Rheumatologist, Al Biraa Arthritis & Bone Centre, Dubai
|
|
9.50 am |
International Speaker: Sponsored by Abbott.
The Benefits Of Early Treatment With Biologics, For The Disease Activity And Implications
Mary Cifaldi, Director, Global Health Economic Outcomes and Research (HEOR) |
|
10.20am |
International Speaker: Sponsored by MSD
Pharmacoeconomics of Biologics in RA
Dr. Shuvayu Sankar Sen, Senior Director, Global Human Health & Outcomes Research MSD, New Jersey, USA |
|
10.50am |
Patient Case Study: Patient With Severe Ankylosing Spondylitis, Who Is Unable To Financially Support Themselves
Dr. Waleed AlShehhi, Consultant Rheumatologist, Al Biraa Arthritis & Bone Centre, Dubai |
|
11.10am |
Patient: A Patient suffering from RA, who is not able to find Health Insurance for the low cost Arthritis treatment. |
|
11.20am |
Patient: An Emirati patient suffering from Ankylosing Spondylitis, who has had difficulties within the UAE system and finding insurance. |
|
11.30am |
Patient: An Arabic Patient who suffers with RA and is not able to afford her own treatment |
|
11.40am |
International Speaker: Sponsored by MSD
Prediction of Rapid Radiographic Progression in Rheumatoid Arthritis Patients
Prof. Josef Smolen, MD, Professor and Chairman, Department of Rheumatology, Medical University of Vienna, Vienna, Austria |
|
12.10pm |
Novartis Q&A |
|
12.30pm – 1.30pm |
LUNCH |